Bupropion Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Bupropion Price Trend, Index and Forecast
Track the latest insights on bupropion price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Bupropion Prices Outlook Q3 2025
- USA: USD 79146/MT
- China: USD 73637/MT
- Germany: USD 85413/MT
- Canada: USD 85934/MT
- Brazil: USD 92173/MT
Bupropion Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the bupropion prices in the USA reached 79146 USD/MT in September. Prices exhibited an upward trajectory driven by tight raw material availability and elevated production costs. Increased demand from pharmaceutical manufacturers, coupled with regulatory inspections impacting production schedules, contributed to the price surge. Additionally, logistics constraints and higher energy expenses further amplified costs.
During the third quarter of 2025, the bupropion prices in China reached 73637 USD/MT in September. Prices rose due to constrained domestic production and heightened demand from both local and international pharmaceutical industries. Regulatory tightening on intermediate chemicals affected output, while supply chain disruptions added to logistical costs. Producers increased prices to offset rising operational expenses and to balance demand-supply disparities.
During the third quarter of 2025, the bupropion prices in Germany reached 85413 USD/MT in September. Price increases were influenced by limited production capacity and higher procurement costs of raw materials. Industrial regulations and quality control measures slowed output, creating supply constraints. Growing pharmaceutical demand and international procurement activities contributed to firm pricing.
During the third quarter of 2025, the bupropion prices in Canada reached 85934 USD/MT in September. Price growth was primarily driven by tight supply due to limited domestic output and increased import reliance. Rising operational and transportation costs further influenced pricing trends. Strong demand from pharmaceutical manufacturers and institutional buyers reinforced upward pressure. Regulatory oversight and compliance requirements caused temporary production slowdowns, tightening available supply.
During the third quarter of 2025, the bupropion prices in Brazil reached 92173 USD/MT in September. Prices climbed due to production bottlenecks and elevated raw material costs. Logistic inefficiencies and increased energy expenses added to upward pressure. High domestic demand, combined with import dependencies, maintained strong pricing levels. Market actors adjusted procurement strategies to secure supply amid volatility, contributing to further price firmness.
Bupropion Prices Outlook Q2 2025
- USA: USD 77420/MT
- China: USD 72200/MT
- Germany: USD 84010/MT
- Canada: USD 84890/MT
- Brazil: USD 91080/MT
During the second quarter of 2025, the bupropion prices in the USA reached 77420 USD/MT in June. As per the bupropion price chart, the rising prices for key inputs, complex manufacturing processes pushed production costs upward, laying prominent pressure on overall pricing. Besides, trade disruptions and shipping delays added costs and unpredictability, weakening supply stability and encouraging price increases.
During the second quarter of 2025, the bupropion prices in China reached 72200 USD/MT in June. Container freight benchmarks stabilized in Q2, taking some pressure off export-linked supply chains for pharmaceutical intermediates and packaging. Lower freight bills reduced the delivered cost base. Besides, regulatory factors maintained a weight too. Policy-driven limitations, manufacturing compliance hurdles, and distribution restrictions added friction to supply and impacted pricing.
During the second quarter of 2025, bupropion prices in Germany reached 84010 USD/MT in June. Prices in Germany were shaped mainly by the country’s reference price system. Moreover, strong competition from other generic brands and parallel imports kept retail prices close to the set reference price, with little room for manufacturers to push them higher. Overall, prices were kept in check by regulation, insurer contracts, competition, and policies to protect supply.
During the second quarter of 2025, the bupropion prices in Canada reached 84890 USD/MT in June. Growing awareness of mental health issues and stronger smoking‑cessation initiatives propelled demand for bupropion HCL. That surge exerted upward pressure on prices, as pharmacies faced heightened consumer interest alongside steady production capacity. Patent expirations and the entry of multiple generics had started to counteract those price hikes. Competition increased among manufacturers and retailers, which helped soften the cost burden on patients and prevented runaway pricing despite strong demand.
During the second quarter of 2025, the bupropion prices in Brazil reached 91080 USD/MT in June. Bupropion prices in Brazil were shaped by a combination of rising demand, growing generic competition, and ongoing pharmaceutical innovation. The expanding use of bupropion for both depression and smoking cessation intensified purchasing activity from pharmacies and healthcare providers. Public health initiatives promoting smoking reduction and greater recognition of mental health conditions also kept demand high. This consistent upward pull on consumption put pressure on supply chains, encouraging suppliers to maintain competitive pricing strategies to capture market share.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing bupropion prices.
Europe Bupropion Price Trend
Q3 2025:
During the third quarter of 2025, the bupropion price index in Europe showed a strong upward trend. Supply constraints, primarily due to stricter production regulations and compliance measures, affected availability. High energy costs and increased procurement expenditures contributed to the sustained price rise. International demand recovery, especially from North America and Asia, intensified market competition. Pharmaceutical manufacturers faced inventory adjustments and strategic buying, reinforcing upward pressure.
Q2 2025:
Bupropion prices in Europe reflected the combined effects of heightened demand, competitive market forces, and ongoing product development. The sustained rise in prescriptions for both depression treatment and smoking cessation continued to drive strong purchasing activity across multiple healthcare systems. Public awareness campaigns on mental health and anti-smoking measures maintained steady pressure on supply channels, prompting suppliers to balance availability with competitive pricing to retain market position. The expansion of the generic segment after patent expirations remained a central factor in shaping price movements. With more generic manufacturers operating in the region, procurement processes, especially within national health services, became more competitive, leading to broader access and downward pressure on market prices. Large-scale tenders and centralized purchasing policies in certain countries amplified this effect, as suppliers competed for contracts that would secure volume sales.
This analysis can be extended to include detailed bupropion price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Bupropion Price Trend
Q3 2025:
During the third quarter of 2025, the bupropion price index in North America reflected significant growth. Limited raw material availability, elevated production costs, and supply chain disruptions drove the upward movement. Strong demand from domestic pharmaceutical sectors and institutional buyers compounded the price increase. Logistic challenges and regulatory oversight further influenced pricing trends. Market participants adapted procurement strategies to maintain continuity, contributing to firm regional prices.
Q2 2025:
As per the bupropion price index, manufacturers responded to growing demand from the pharmaceutical sector by leaning on imports, since domestic production remained limited. That made them more exposed to price swings in global raw material markets and the logistics needed for transport. Global supply chain disruptions and shifts in trade policy added tension to the market, reinforcing cost pressures as transporting and sourcing materials got more complex. Besides, manufacturing cost increases, stemming from raw material availability and production constraints, further nudged prices upward. Those cost pressures were felt most keenly by US buyers reliant on external suppliers.
Specific bupropion historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Bupropion Price Trend
Q3 2025:
The report explores the bupropion trends and bupropion price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
As per the bupropion price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
In addition to region-wise data, information on bupropion prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Bupropion Price Trend
Q3 2025:
During Q3 2025, bupropion prices in the Asia Pacific exhibited upward momentum. Production slowdowns due to regulatory inspections and raw material procurement challenges affected supply. Elevated logistics and energy expenses, combined with increased regional demand, contributed to price escalation. Manufacturers adjusted production and distribution strategies to manage supply-demand imbalances, sustaining higher prices throughout the quarter.
Q2 2025:
Market prices were shaped largely by supply‑chain frictions. Freight carriers faced softer demand for containers, yet costs rose on account of disruptions like rerouting and shipping lanes remained volatile due to geopolitical tensions and extended routes. This fluctuation exerted upward pressure on drug supply logistics across Asia‑Pacific. Regulatory oversight tightened in key manufacturing hubs. Raw material shortages also played their part. Inputs feeding into bupropion synthesis, such as precursor chemicals, faced intermittent bottlenecks.
This bupropion price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Bupropion Price Trend
Q3 2025:
The bupropion prices in Latin America saw considerable increases. Supply constraints, high operational costs, and import dependencies intensified pricing pressures. Strong demand from the pharmaceutical industries reinforced upward trends. Logistic inefficiencies and regulatory compliance further tightened market availability, supporting elevated price levels across the region.
Q2 2025:
As per the bupropion price index, demand signals were steady to firm across antidepressants, and market trackers highlighted renewed attention on mood disorder treatments. This backdrop supported negotiating positions for some suppliers, even as competitive tendering kept caps in place in public channels. Besides, product-specific monitoring pointed to cautious sentiment around bupropion itself. Pricing services referenced prior swings tied to production costs, shipping, and compliance events, and buyers in the region priced these risks into contracts during Q2.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Bupropion Pricing Report, Market Analysis, and News
IMARC's latest publication, “Bupropion Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the bupropion market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of bupropion at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed bupropion prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting bupropion pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Bupropion Industry Analysis
The global bupropion market size reached USD 1.6 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 2.5 Billion, at a projected CAGR of 5.27% during 2026-2034. The market is primarily driven by the rising pharmaceutical demand, increasing prevalence of depression and nicotine addiction treatments, and expanded production capacity.
Latest News and Developments:
- January 2025: Axsome Therapeutics’ AXS-05, a combination of dextromethorphan and bupropion, showed promising results in treating Alzheimer’s disease (AD) agitation. In the phase 3 ACCORD-2 trial, AXS-05 significantly delayed relapse compared with placebo and reduced worsening of overall AD severity. In the ADVANCE-2 trial, AXS-05 showed numerically better reductions in agitation scores, though the primary endpoint was not met.
Product Description
Bupropion refers to an atypical antidepressant medication majorly utilized to treat major depressive disorder (MDD) and seasonal affective disorder (SAD). In addition to this, this medication is also prescribed to help with smoking cessation. Unlike other antidepressants, bupropion does not fit neatly into the categories of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors. Instead, it majorly inhibits the reuptake of norepinephrine and dopamine, increasing their levels in the brain. This unique mechanism of action makes bupropion useful for patients who do not respond well to traditional antidepressants.
Bupropion is marketed under different brand names such as Zyban and Wellbutrin. In line with this, it is generally well-tolerated, though side effects include dry mouth, headaches, and insomnia. Bupropion’s lower risk of sexual side effects compared to SSRIs adds to its appeal.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Bupropion |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Bupropion Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of bupropion pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting bupropion price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The bupropion price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.